Journal of Diabetes Research / 2021 / Article / Tab 3 / Research Article
Effectiveness of Ascophyllum nodosum and Fucus vesiculosus on Metabolic Syndrome Components: A Real-World, Observational Study Table 3 Estimated marginal means (95% CI) of the parameters of interest at baseline and their change after 90 days and 180 days of treatment, by tertiles of baseline values or clinically meaningful classes (for FBG and HbA1c).
Parameter Baseline value Change at 90 days value (90 days vs. baseline)Change at 180 days value (180 days vs. baseline)Weight (kg) I 75.2 [73.6; 76.8] -3.1 [-3.5; -2.7] <0.0001 -4.7 [-5.5; -3.9] <0.0001 II 87.9 [86.8; 89.1] -3.7 [-4.1; -3.2] <0.0001 -6.2 [-6.8; -5.5] <0.0001 III 109.3 [106.6; 112.0] -6.9 [-8.5; -5.3] <0.0001 -10.8 [-12.7; -9.0] <0.0001 Waist circumference (cm) I 91.8 [89.8; 93.8] -3.1 [-3.5; -2.6] <0.0001 -5.4 [-6.1; -4.8] <0.0001 II 106.2 [105.0; 107.5] -4.5 [-5.1; -3.9] <0.0001 -8.1 [-9.0; -7.3] <0.0001 III 126.9 [124.8; 129.1] -5.7 [-6.9; -4.5] <0.0001 -9.5 [-11.1; -7.8] <0.0001 Fasting blood glucose (mg/dL) <110 89.5 [85.2; 93.9] -2.1 [-3.7; -0.6] 0.007 -3.1 [-5.5; -0.7] 0.013 110-125 112.8 [11.7; 114.0] -8.1 [-9.2; -7.1] <0.0001 -12.8 [-14.1; -11.5] <0.0001 >125 141.8 [138.5; 145.1] -15.5 [-17.9; -13.0] <0.0001 -23.5 [-26.3; -20.7] <0.0001 HbA1c (%) <6.0 5.48 [5.36-5.59] -0.18 [-0.26; -0.10] <0.0001 -0.27 [-0.38; -0.16] <0.0001 6.0-6.5 6.25 [6.21-6.29] -0.20 [-0.25; -0.15] <0.0001 -0.41 [-0.49; -0.32] <0.0001 6.6-7.0 6.83 [6.80-6.86] -0.38 [-0.49; -0.28] <0.0001 -0.58 [-0.69; -0.47] <0.0001 >7.0 7.74 [7.60-7.87] -0.52 [-0.67; -0.37] <0.0001 -0.86 [-1.00; -0.72] <0.0001 Systolic blood pressure (mmHg) I 117.2 [115.2; 119.3] 0.3 [-1.4; 2.1] 0.69 0.17 [-2.8; 1.2] 0.86 II 135.1 [134.3; 135.9] -4.7 [-5.8; -3.7] <0.0001 -6.6 [-7.8; -5.5] <0.0001 III 152.4 [150.0; 154.8] -10.3 [-12.3; -8.4] <0.0001 -16.3 [-18.7; -12.4] <0.0001 Diastolic blood pressure (mmHg) I 70.1 [68.5; 71.6] 0.9 [-0.5; 2.2] 0.22 0.9 [-0.8; 2.6] 0.29 II 81.5 [81.2; 81.9] -2.2 [-2.9; -1.5] <0.0001 -3.7 [-4.5; -2.8] <0.0001 III 93.1 [90.2; 95.9] -6.0 [-7.1; -4.9] <0.0001 -9.4 [-10.6; -8.1] <0.0001 LDL cholesterol (mg/dL) I 95.5 [91.2; 97.7] -2.3 [-6.2; 1.7] 0.25 -3.7 [-8.3; 0.9] 0.11 II 131.4 [129.5; 133.3] -11.3 [-13.9; -8.7] <0.0001 -18.6 [-21.8; -15.3] <0.0001 III 168.9 [163.2; 174.6] -19.9 [-23.9; -16.0] <0.0001 -32.5 [-37.7; -27.2] <0.0001 HDL cholesterol (mg/dL) I 37.0 [35.9; 38.2] 4.0 [2.8; 5.3] <0.0001 6.6 [5.1; 8.1] <0.0001 II 47.1 [46.1; 48.1] 3.0 [1.7; 4.4] <0.0001 4.8 [3.2; 6.4] <0.0001 III 67.6 [61.5; 73.8] -3.0 [-9.2; 3.1] 0.33 -3.6 [-9.8; 2.6] 0.25 Triglycerides (mg/dL) I 110.0 [104.4; 115.6] -4.6 [-8.6; -0.6] 0.025 -8.1 [-12.6; -3.7] 0.001 II 168.5 [165.1; 171.9] -20.1 [25.3; -14.9] <0.0001 -25.8 [-32.2; -19.4] <0.0001 III 254.4 [235.0; 273.7] -39.0 [-67.0; -10.9] <0.0001 -72.9 [-86.0; -59.9] <0.0001